ZION Stock Analysis: Zions Bancorporation | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 9.138m USD | 12M Return: 14.7% | US9897011071 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 95.1M
EPS Trend: 78.7%
Qual. Beats: 5
Rev. Trend: 79.9%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Zions Bancorporation (ZION) is a regional U.S. bank holding company headquartered in Salt Lake City, Utah, founded in 1873. It operates primarily across 11 western states through seven distinct bank charters, including Zions Bank, California Bank & Trust, Amegy Bank, and National Bank of Arizona. The company provides a full suite of commercial banking, small business lending, retail banking, wealth management, and capital markets/investment banking services. Its multi-brand structure reflects a growth strategy built largely through the acquisition and integration of regional banks, a common approach among U.S. regional banks seeking scale and geographic diversification while maintaining local market identity. The company rebranded from ZB, National Association to its current name in September 2018.
- Net interest margin expansion lifts earnings amid elevated rates
- Commercial real estate loan losses threaten credit quality
- Deposit costs pressure margins as competition for funding intensifies
| Net Income: 1.17b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.57 > 1.0 |
| NWC/Revenue: -1.09k% < 20% (prev -1.36k%; Δ 272.4% < -1%) |
| CFO/TA 0.02 > 3% & CFO 2.19b > Net Income 1.17b |
| Net Debt (-18.2b) to EBITDA (1.61b): -11.26 < 3 |
| Current Ratio: 0.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (146.2m) vs 12m ago -0.57% < -2% |
| Gross Margin: 71.41% > 18% (prev 63.85%; Δ 7.56% > 0.5%) |
| Asset Turnover: 5.81% > 50% (prev 5.59%; Δ 0.21% > 0%) |
| Interest Coverage Ratio: 1.05 > 6 (EBIT TTM 1.50b / Interest Expense TTM 1.43b) |
| A: -0.63 (Total Current Assets 21.4b - Total Current Liabilities 77.8b) / Total Assets 89.0b |
| B: 0.09 (Retained Earnings 7.88b / Total Assets 89.0b) |
| C: 0.02 (EBIT TTM 1.50b / Avg Total Assets 89.0b) |
| D: 0.09 (Book Value of Equity 7.68b / Total Liabilities 81.4b) |
| Altman-Z'' = -3.65 = D |
As of October 06, 2026, the stock is trading at USD 63.28 with a total of 1,307,428 shares traded. Over the past week, the price has changed by +0.14%, over one month by -7.44%, over three months by -9.77% and over the past year by +14.67%.
Current recommended Stop Loss: 60.20 (which is 4.9% or 2.2 ATR below the current price).
Zions Bancorporation has received a consensus analysts rating of 3.57. Therefore, it is recommended to hold ZION.
- StrongBuy: 6
- Buy: 1
- Hold: 13
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 74.8 | 18.2% |
P/E Trailing = 7.9758
P/E Forward = 9.1491
P/S = 2.4785
P/B = 1.2008
P/EG = 3.9765
Revenue TTM = 5.17b USD
EBIT TTM = 1.50b USD
EBITDA TTM = 1.61b USD
Long Term Debt = 1.95b USD (from longTermDebt, last quarter)
Short Term Debt = 1.22b USD (from shortTermDebt, last quarter)
Debt = 3.18b USD (from shortLongTermDebtTotal, last quarter) + Leases 3.00m
Net Debt = -18.2b USD (calculated: Debt 3.18b - CCE 21.4b)
Enterprise Value = 9.14b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 1.05 (Ebit TTM 1.50b / Interest Expense TTM 1.43b)
EV/FCF = 4.46x (Enterprise Value 9.14b / FCF TTM 2.05b)
FCF Yield = 22.41% (FCF TTM 2.05b / Enterprise Value 9.14b)
FCF Margin = 39.64% (FCF TTM 2.05b / Revenue TTM 5.17b)
Net Margin = 22.67% (Net Income TTM 1.17b / Revenue TTM 5.17b)
Gross Margin = 71.41% ((Revenue TTM 5.17b - Cost of Revenue TTM 1.48b) / Revenue TTM)
Gross Margin QoQ = 76.67% (prev 72.36%)
Tobins Q-Ratio = 0.10 (Enterprise Value 9.14b / Total Assets 89.0b)
Interest Expense / Debt = 44.87% (Interest Expense 1.43b / Debt 3.18b)
Taxrate = 21.99% (330.0m / 1.50b)
NOPAT = 1.17b (EBIT 1.50b * (1 - 21.99%))
Current Ratio = 0.28 (Total Current Assets 21.4b / Total Current Liabilities 77.8b)
Debt / Equity = 0.41 (Debt 3.18b / totalStockholderEquity, last quarter 7.68b)
Debt / EBITDA = -11.26 (Net Debt -18.2b / EBITDA 1.61b)
Debt / FCF = -8.88 (Net Debt -18.2b / FCF TTM 2.05b)
Total Stockholder Equity = 7.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.32% (Net Income 1.17b / Total Assets 89.0b)
RoE = 16.14% (Net Income TTM 1.17b / Total Stockholder Equity 7.26b)
RoCE = 16.30% (EBIT 1.50b / Capital Employed (Equity 7.26b + L.T.Debt 1.95b))
RoIC = 9.62% (NOPAT 1.17b / Invested Capital 12.2b)
WACC = 16.16% (E(9.14b)/V(12.3b) * Re(9.60%) + D(3.18b)/V(12.3b) * Rd(44.87%) * (1-Tc(0.22)))
Discount Rate = 9.60% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -65.51 | Cagr: -0.34%
[DCF] Terminal Value 56.82% ; FCFF base≈1.49b ; Y1≈1.70b ; Y5≈2.51b
[DCF] Fair Price = 232.0 (EV 15.7b - Net Debt -18.2b = Equity 33.9b / Shares 146.0m; r=16.16% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 78.74 | EPS CAGR: 10.49% | SUE: 1.81 | # QB: 5
Revenue Correlation: 79.95 | Revenue CAGR: 5.52% | SUE: 0.98 | # QB: 1
EPS current Quarter (2026-09-30): EPS=1.66 | Chg30d=+0.11% | Revisions=+14% | Analysts=20
EPS current Year (2026-12-31): EPS=7.93 | Chg30d=+1.85% | Revisions=+88% | GrowthEPS=+31.9% | GrowthRev=+5.4%
EPS next Year (2027-12-31): EPS=6.82 | Chg30d=+0.18% | Revisions=+23% | GrowthEPS=-14.0% | GrowthRev=+2.6%
[Analyst] Revisions Ratio: +47% (up=44, down=15)